Nucleic acid testing market outlook

The global market for nucleic acid testing will grow at a CAGR of nearly 10% by 2020. According to the analysts, eminent factors like the higher adoption rate of molecular point-of-care (POC) testing will aid in the strong growth of this market during the forecast period. POC testing provides immediate results in non-laboratory settings to support more patient-centered approaches to healthcare delivery. The sensory technology enables the rapid analysis of blood samples. In the molecular diagnosis field, there is a higher adoption for POC testing systems as it helps in glucose self-testing. Also, due to the high cost of clinical diagnostic devices, the preference for molecular POC testing has increased.

Nucleic acid testing market growth based on geography

In terms of geography, the nucleic acid testing market will witness rapid growth in the Americas. The market in this region is dynamic, with the presence of more than 20 established companies that compete for the sales of nucleic acid testing systems and reagents. The market in this region also provides significant opportunities for vendors, particularly in the US, as private and government research institutes and pharmaceutical companies are extensively adopting genome engineering, next-generation sequencing, and gene editing technologies.

Nucleic acid testing market vendors

The global nucleic acid market is in the nascent stage and is characterized by the presence of large (tier 1), medium (tier 2) and small-sized companies (tier 3) companies. Most of the top-tier companies are present in the Americas and Western Europe. However, in APAC (such as China) there are many local vendors that account for a major share of the market in some areas. Factors such as advances in technology and new product launches also help in increasing the level of competition among vendors.

Top vendors in the nucleic acid testing market

• Abbott Laboratories
• Roche Molecular Systems
• Siemens Healthineers
• Hologic
• Qiagen

Nucleic acid testing market segmentation by technology

• PCR
• SDA
• LCR

According to this market analysis, the polymerase chain reaction (PCR) segment will continue its market dominion until the end of 2020. PCR is one of the techniques in molecular biology, which is used for the amplification of genetic material such as DNA/RNA. It is one of the cheapest tools available for the diagnosis and detection of infectious diseases, paternity disputes, cancer, and other genetic disorders.

Nucleic acid testing market segmentation by end-users 

• Hospitals
• Clinics
• Research institutes

Hospitals are an integral part of disease diagnosis, treatment, monitoring response to treatment, disease surveillance programs, and clinical research. The use of molecular diagnostic techniques helps in early diagnosis enabling appropriate and prompt intervention, thereby, reducing overall disease burden and promoting health. The data obtained from patient samples is used for the analysis and development of personalized medicines, and this is only possible in the laboratory setting of hospitals.

 Key questions answered in the report include

• What will the market size and the growth rate be in 2020?
• What are the key factors driving the global nucleic acid testing market?
• What are the key market trends impacting the growth of the global nucleic acid testing market?
• What are the challenges to market growth?
• Who are the key vendors in the global nucleic acid testing market?
• What are the market opportunities and threats faced by the vendors in the global nucleic acid testing market?
• What are the key outcomes of the five forces analysis of the global nucleic acid testing market?

Technavio also offers customization on reports based on specific client requirement.